Frequency of preeclampsia and severe preeclampsia in women following recovery from TTP associated with acquired, severe ADAMTS13 deficiency compared with US population estimates
| Occurrence . | Frequency: Oklahoma patients (95% CIs) . | Frequency: US population . | |
|---|---|---|---|
| 1 . | 2 . | ||
| Per pregnancy | |||
| Preeclampsia | 5/16, 31.3% (11.0, 58.7) | 2.4%-3.2% | 2.1% |
| Severe preeclampsia | 3/16, 18.8% (4.0, 45.7) | NA | 1.0%-1.2% |
| Per woman | |||
| Preeclampsia | 3/10, 30.0% (6.7, 65.3) | NA | NA |
| Severe preeclampsia | 2/10, 20.0% (2.5, 55.6) | NA | NA |
| Occurrence . | Frequency: Oklahoma patients (95% CIs) . | Frequency: US population . | |
|---|---|---|---|
| 1 . | 2 . | ||
| Per pregnancy | |||
| Preeclampsia | 5/16, 31.3% (11.0, 58.7) | 2.4%-3.2% | 2.1% |
| Severe preeclampsia | 3/16, 18.8% (4.0, 45.7) | NA | 1.0%-1.2% |
| Per woman | |||
| Preeclampsia | 3/10, 30.0% (6.7, 65.3) | NA | NA |
| Severe preeclampsia | 2/10, 20.0% (2.5, 55.6) | NA | NA |
US population estimates per pregnancy are from 2 studies: (1) Preeclampsia: The National Hospital Discharge Survey public-use dataset, 1996-2004.15 (2) Preeclampsia and severe preeclampsia: The Nationwide Inpatient Sample of the Healthcare Cost and Utilization Project, 1998-2006.16 US population estimates per individual woman are not available.
NA, not available.